“…The inclusion criteria were as follows: age between 18 and 75 years with first acute ischemic stroke of the anterior circulation system within 2–10 days, stable medical condition, conscious and alert, able to follow commands, and a Modified Rankin Scale (mRS) score of ≤ 4. Participants were excluded if they had a hemorrhagic stroke, recurrent stroke, unilateral neglect, pusher syndrome, other neurological disorders (e.g., normal pressure hydrocephalus), contraindication to tDCS (i.e., metal implantation, intracranial shunt, cardiac pacemakers, open or infectious wound around the scalp, history of epilepsy), or any factor that could interfere with EEG (i.e., ischemic heart disease, peripheral vascular ischemia, late-stage kidney or liver disease, body mass index > 30 kg/m 2 , or undergoing hormonal treatment [ 34 – 37 ]). All medications were recorded; none of the participants received any medications that could affect tDCS efficacy (i.e., sodium and calcium channel blockers) [ 38 ].…”